Annual Drug Patent Expirations for APRETUDE
Apretude is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier.
The generic ingredient in APRETUDE is cabotegravir. One supplier is listed for this compound. Additional details are available on the cabotegravir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com